Celldex Therapeutics Inc (NASDAQ:CLDX)

25.54
Delayed Data
As of Feb 27
 +0.60 / +2.41%
Today’s Change
10.76
Today|||52-Week Range
31.88
+39.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues9.3M11.2M4.1M3.6M
 
 
 
 
 
Cost of Goods Sold6.9M8.7M2.3M0.00
 
 
 
 
Depreciation And Amortization4.2M3.1M2.9M--
 
 
 
 
 
Operating ExpensesGross Income-1.8M-663.0K-1.2M3.6M
 
 
 
 
 
General Expenses41.7M57.4M80.3M125.0M
 
 
 
 
 
Other Operating Expenses0.000.000.001.0M
 
 
Research And Development32.4M47.4M65.5M104.4M
 
 
 
 
 
Total Operating Expenses52.7M69.3M85.6M126.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-43.4M-58.1M-81.4M-122.4M
 
 
 
 
 
Interest Expense On Debt1.8M1.6M927.0K0.00
 
 
 
 
Other Expenses50.0K100.0K0.00--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.8M-59.1M-81.6M--
 
 
 
 
Net Income-44.8M-59.1M-81.6M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.5M57.7M79.8M89.4M
 
 
 
 
 
Shares To Calculate EPS Diluted39.5M57.7M79.8M89.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.13-$1.02-$1.02-$1.32
 
 
 
 
 
EPS Diluted-$1.13-$1.02-$1.02-$1.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account